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Edited by Hans-Dieter KlenkAbstract It has been shown that severe acute respiratory syn-
drome-associated coronavirus (SARS-CoV) 3a and 7a proteins,
but not membrane (M) protein, induce apoptosis in mammalian
cells. Upon expression of SARS-CoV M protein using the bacu-
lovirus/insect cell expression system, however, we found that the
expressed M protein triggered accelerated apoptosis in insect
cells, as characterized by rapid cell death, elevated cytotoxicity,
cell shrinkage, nuclear condensation and DNA fragmentation.
Conversely, the M protein expressed in mammalian cells did
not induce apoptosis. This is the ﬁrst report describing the induc-
tion of apoptosis by SARS-CoV M protein in animal cells and
possible implications are discussed.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Severe acute respiratory syndrome (SARS) is a newly de-
scribed infectious disease and a novel SARS-associated coro-
navirus (SARS-CoV) has been identiﬁed as the causative
agent. SARS-CoV possesses a positive single-stranded RNA
genome (29727 nucleotides) encoding at least ﬁve structural
proteins: spike (S), membrane (M), envelope (E), nucleocapsid
(N) proteins [1–3] and the newly identiﬁed ORF3a [4]. The S
glycoprotein mediates virus binding to the target cells and sub-
sequent membrane fusion [5]. The N protein binds to a deﬁned
packaging signal on the RNA, leading to formation of the heli-
cal nucleocapsids [6]. The E protein is a minor yet critical
structural component in coronavirus assembly. The M glyco-
protein is the most abundant structural protein on the viral
envelope; it is a triple-spanning membrane protein with a long
carboxyl-terminal tail in the virion interior which interacts
with the E and S proteins during assembly [7], hence M protein
has been implicated as a key player in coronavirus assembly
and budding [7]. Besides, monoclonal antibodies to the M pro-
tein of mouse hepatitis virus (MHV), a mouse coronavirus,
could neutralize virus infectivity in vitro and protect animals*Corresponding author. Fax: +886 3 571 5408.
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doi:10.1016/j.febslet.2006.06.003against lethal viral challenge in vivo [8]. Antiserum to M pro-
tein was found to contain neutralizing antibody towards
SARS-CoV infection in vivo [9]. SARS patients-derived
human recombinant antibodies to M protein also eﬃciently
neutralize SARS-CoV infectivity [10] and two immunodomi-
nant epitopes (a.a. 1–31 and a.a. 132–161) on the SARS-
CoV M protein have been recently identiﬁed [11].
Among the proteins SARS-CoV encodes, we were interested
in M protein due to its key role in the induction of neutralizing
antibodies and virus assembly. To further characterize the
structure and functions of SARS-CoV M protein, large quan-
tities of puriﬁed proteins are required. Therefore, we aimed at
developing a method for mass production of SARS-CoV M
protein. Owing to the generally high production yield, ease
of virus construction and safety, baculovirus/insect cell expres-
sion system was selected for the expression of recombinant M
protein with or without histidine (His6) tags. Surprisingly, we
found that the expression of SARS-CoV M protein in insect
cells triggered early induction of apoptosis, and led to exceed-
ingly low expression level. This is the ﬁrst report regarding the
induction of apoptosis in animal cells by the expression of
SARS-CoV M protein.2. Materials and methods
2.1. Cells and media
Sf-9 cells were maintained in spinner ﬂasks using TNM-FH medium
[12]. HuH-7 (human hepatoma), Vero E6 (African green monkey kid-
ney epithelial), 293 (human embryonic kidney), HeLa (human cervix
carcinoma) and RD (human muscle rhabodomyosarcoma) cells were
maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM). A549
(human lung carcinoma) and BEAS-2B (human lung bronchus epithe-
lial) cells were maintained in RPMI 1640 medium. All culture media
were supplemented with 10% fetal bovine serum (Gibco BRL). The cell
density was counted by a hemacytometer and the viability was deter-
mined by trypan blue dye exclusion.
2.2. Construction of recombinant plasmids and baculoviruses
The recombinant baculovirus expressing the histidine-tagged (His6)
N protein (rNH), vBacNH, was constructed previously [13]. To con-
struct the recombinant baculovirus expressing M protein, the full-
length gene fragment of SARS-CoV M protein (TW1 strain, GenBank
Accession No. AY291451) was ampliﬁed by polymerase chain reaction
(PCR) from the vector provided by Prof. Pei-Jer Chen (College of
Medicine, National Taiwan University) and subsequently subcloned
into pFastBac HTb (Invitrogen). The subcloning resulted in the fusion
of a His6 tag at the N-terminus of M gene under the control of poly-
hedrin promoter. Alternatively, the M gene was PCR-ampliﬁed andblished by Elsevier B.V. All rights reserved.
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were designated pBac-MH and pBac-M, respectively (Fig. 1). For pro-
tein expression in mammalian cells, the polyhedrin and p10 promoters
in the pFastBac DUAL vector (Invitrogen) was deleted, and replaced
by cytomegalovirus immediate-early promoter (CMV-IE) which was
PCR-ampliﬁed from pcDNA3.0 plasmid (Invitrogen). The gene frag-
ments encoding the M protein with or without His6 tag were PCR-
ampliﬁed from pBac-MH and pBac-M, respectively and subcloned
into the corresponding site downstream of the CMV-IE promoter.
The resultant plasmids were designated pBacMam-MH and pBac-
Mam-M (Fig. 1). Similarly, the gene encoding enhanced yellow ﬂuores-
cent protein (EYFP) was cloned under the control of CMV-IE
promoter to obtain pBacMam-EYFP. The recombinant baculoviruses
were generated based on these plasmids using Bac-to-Bac system
(Invitrogen) and designated vBacMH, vBacM, vBacMam-MH, vBac-
Mam-M and vBacMam-EYFP, respectively. The storage, ampliﬁca-
tion and titration of the recombinant baculoviruses were performed
as described [14].
2.3. Western blot analysis
Sf-9 cells were infected by recombinant baculovirus at a multiplicity
of infection (MOI) of 10, and collected at three days post-infection
(dpi). The Western blot analysis of rNH protein was performed as de-
scribed [13]. To detect rMH protein, the vBacMH-infected cells
(1 · 106 cells) were lysed in 100 ll RIPA buﬀer (20 mM Tris–HCl,
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
pH 7.5) for 30 min on ice. After centrifugation (13000 rpm, 30 min),
lysates and pellets were treated at 95 C for 5 min or 37 C for
30 min in the sample buﬀer. The samples were resolved in the 12%
SDS–PAGE, and electrotransferred to nitrocellulose membranes for
Western blot following standard procedures (Bio-Rad Laboratories).
The primary antibody was mouse anti-His6 MAb (1:1500 dilution,
Amersham Biosciences) while the secondary antibody was horseradish
peroxidase-conjugated goat anti-mouse IgG (1:1000 dilution, Kirkeg-
aard and Perry Laboratories). The membranes were developed with
chemiluminescence reagent (ECL Western Blotting Substrate, Pierce).
2.4. MTT assay
The cytotoxicity resulting from protein expression in Sf-9 cells was
analyzed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl tetrazo-
lium bromide, Sigma) assay. The cells (5 · 105 cells/ml) were infectedpolh His6 SV40 polyA pBac-MH
SARS-M
SV40 polyA polhpBac-M
SARS-M
SV40 polyA CMV-IEpBacMam-M
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Fig. 1. Schematic illustration of the recombinant baculovirus vectors,
pBac-MH, pBac-M, pBacMam-MH, pBacMam-M and pBacMam-
EYFP. CMV-IE, cytomegalovirus immediate-early promoter; polh,
polyhedrin promoter.at MOI 10, seeded into 96-well plates (100 ll/well) and cultured at
27 C for three days. At the end of culture, 10 ll MTT (5 mg/ml) dis-
solved in phosphate buﬀer-saline (PBS) was added. After 3 h of incu-
bation at 27 C, the solution was withdrawn, followed by the
addition of 100 ll dimethyl sulfoxide (Sigma) to solublize the MTT
reduction product, formazan. The color change was recorded by
OD570 10 min later. The cytotoxicity was calculated by the formula:
1  ODsample/ODcontrol, where the control was the infected cell at
0.5 dpi.
2.5. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling (TUNEL) assay
The DNA fragmentation was analyzed by ﬂow cytometry coupled
with a TUNEL assay. The cells were infected at MOI 10, collected
at 2 dpi and treated with ApoAlert DNA Fragmentation Assay Kit
according to the manufacturer’s instructions (BD Biosciences).
Approximately 10000 cells from each sample were examined by ﬂow
cytometry (FACSCalibur, BD Biosciences) to measure ﬂuorescin iso-
thiocyanate (FITC) labeling. The mock-infected cells were treated in
the same way and set at 1% as TUNEL-negative control.
2.6. DNA fragmentation by electrophoresis
The cells were seeded onto T-75 ﬂasks (1 · 107 cells/ﬂask) and in-
fected at MOI 10. Cells were collected at 3 dpi, washed with PBS,
and lysed in 750 ll lysis buﬀer (20 mM Tris, 10 mM EDTA, 0.5%
SDS and 0.5% RNase A, pH 8.0) at 37 C for 1 h. After centrifugation
(13000 rpm for 15 min), 60 ll proteinase K (7 mg/ml) was added and
the incubation continued at 55 C for 2.5 h. At the end of incubation,
genomic DNA in the mixture was extracted with phenol/chloroform/
isoamyl alcohol (24:25:1) and chloroform, followed by precipitation
with isopropanol. After drying, the DNA pellet was resuspended in
50 ll TE buﬀer and subject to 2% agarose gel electrophoresis.
2.7. Determination of sub-G1 phase percentage in baculovirus-transduced
mammalian cells
Baculovirus transduction of mammalian cells was performed as de-
scribed previously [15]. At 2 days post-transduction (dpt), the cells
were harvested and resuspended in PBS. After ﬁxing with alcohol at
20 C overnight, the cells were centrifuged (1500 rpm for 5 min),
resuspended in PI (propidium iodide) staining solution (10 lg PI and
1 mg RNase A per milliliter PBS), and incubated at 37 C for
45 min. Finally, the cells were analyzed by ﬂow cytometer at FL-2
ﬁlter.
2.8. Statistical analysis
Quantitative data were analyzed using Student’s t-tests and are ex-
pressed as means ± standard deviation (S.D.) or mean values of three
or four independent experiments. P-values less than 0.05 were consid-
ered signiﬁcant.3. Results
3.1. Expression of the rMH protein in Sf-9 cells
To conﬁrm the expression of His6-tagged M protein, rMH,
Sf-9 cells were infected by vBacMH (MOI 10), harvested at
3 dpi and analyzed by Western blot. In parallel, cells were also
infected by vBacNH and the expression of His6-tagged N pro-
tein (rNH) was analyzed as a control. As shown in Fig. 2 (left
panel), rNH protein (50 kDa) was expressed abundantly and
readily extracted into the cell lysates (lys). In sharp contrast,
nearly no His6-tagged rMH was detectable using BCIP/NBT
for color development (data not shown), indicating the low
expression level. Consequently, chemiluminescence enhance-
ment was employed for imaging. By incubating the
vBacMH-infected cell lysates (lys) and pellets (pel) at 95 C
for 5 min, however, rMH proteins were stuck at the interface
of stacking and separating gels (right panel). Therefore, the
samples were incubated at 37 C for 30 min prior to electro-
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Fig. 3. Time-course proﬁles of viability (A) and cytotoxicity (B) of
the cells infected by wt AcMNPV, vBacNH, vBacM and vBacMH at
MOI 10. The data represent the means ± S.D. of four independent
experiments.
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Fig. 2. Western blot analysis of the lysates (lys) and pellets (pel) of Sf-9
cells infected by vBacNH and vBacMH. The primary antibody was
mouse anti-His6 MAb while the secondary antibodies were either AP-
(for rNH detection) or HRP-conjugated (for rMH detection) goat anti-
mouse IgG. The membranes were developed with either BCIP/NBT
color developing reagent or chemiluminescence reagent.
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with a molecular mass of 29 kDa was detected in the pellets
fraction, but was barely detectable in the lysates fraction,
indicating the strong association of rMH protein with cell
membranes.
3.2. Cell death kinetics and cytotoxic eﬀect
Upon vBacMH infection of cells, we noted that the cells died
abnormally rapidly, thus Sf-9 cells were infected by wild-type
AcMNPV (wt), vBacNH and vBacMH at MOI 10 and the
death kinetics was monitored by trypan blue staining
(Fig. 3A). As shown, the viability of cells infected by wt
AcMNPV and vBacNH declined slowly and remained higher
than 55% at 3 dpi. Surprisingly, the viability of vBacMH-in-
fected cells started to decrease sharply at 1.5 dpi, and precipi-
tously dropped to 20% at 3 dpi, suggesting strong adverse
eﬀects of rMH expression on Sf-9 cells. To examine whether
the dramatic decrease of cell viability resulted from the His6
tag fused to M protein, we constructed vBacM expressing
rM devoid of the His6 tag for infection. Likewise, the
vBacM-infected cells exhibited rapid death kinetics and the
viability dropped below 20% at 3 dpi.
To verify the distinction in cell death kinetics, the cytotoxic-
ity of infected cells was analyzed at diﬀerent time points by
MTT assays (Fig. 3B). Compared to the wt AcMNPV infec-
tion, vBacNH infection resulted in similar cytotoxicity,
whereas the vBacMH and vBacM infection led to signiﬁcantly
higher cytotoxicity (P < 0.05). Such elevated cytotoxicity upon
expression of SARS CoV M protein was also observed in
E. coli [16], and was attributed to budding of M protein,
repression of certain host cell genes or alteration of cell mem-
brane permeability.
3.3. Early induction of apoptosis in insect cells expressing rM
and rMH
Loss of cell viability can occur following a toxic insult by
triggering necrosis or apoptosis. Since SARS-CoV infection
causes cell apoptosis in patients [2] or cultured cells [17], wesuspected that the dramatically lower viability for the
vBacMH- and vBacM-infected cells stemmed from the induc-
tion of apoptosis. To explore this hypothesis, Sf-9 cells were
infected as in Fig. 3. Fig. 4A depicts that the cells infected
by wt AcMNPV and vBacNH barely exhibited cytopathic
eﬀect (CPE) at 2 dpi, whereas cell shrinkage and nuclear
condensation were apparently observed for the cells infected
by vBacMH and vBacM. To further conﬁrm the induction
of apoptosis, the infected cells were harvested at 2 dpi for
TUNEL analysis. Fig. 4B illustrates that very low percentages
of cells infected by wt AcMNPV (5.2 ± 1.0%) and vBacNH
(3.2 ± 1.3%) cells were TUNEL-positive, which agreed with
the high cell viabilities (Fig. 3A) and indicated the low degree
of apoptosis in cells infected by wt AcMNPV and vBacNH
at 2 dpi. In contrast, up to 34.3 ± 1.5% of vBacMH-infected
cells and 21.4 ± 3.6% of vBacM-infected cells were TUNEL-
positive.
To visualize the DNA fragmentation, a hallmark of apopto-
sis, induced by diﬀerent baculoviruses, the genomic DNA of
infected cells was extracted at 3 dpi and subject to gel electro-
phoresis. Fig. 4C reveals visible DNA fragmentation for wt
AcMNPV- and vBacNH-infected cells, but DNA laddering
was not apparent. In contrast, low-molecular-weight DNA
fragments appeared at 1.5 dpi (data not shown) and became
clearly visible at 3 dpi for cells infected by vBacM and
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Fig. 4. Induction of apoptosis by vBacMH and vBacM infection of Sf-
9 cells. (A) Photomicrographs showing the cell morphology of Sf-9
cells at 2 dpi after infection with wt AcMNPV, vBacNH, vBacMH and
vBacM at MOI 10. (B) TUNEL staining and ﬂow cytometry analysis
of Sf-9 cells. Sf-9 cells were mock-infected or infected as in (A) and
subject to TUNEL assay at 2 dpi. Samples were analyzed by ﬂow
cytometry and representative experiments are shown. The open and
shaded histograms represent the ﬂuorescence intensities of mock-
infected and baculovirus-infected cells, respectively. The data shown in
the ﬁgures represent the means ± S.D. of four independent experi-
ments. (C) Cellular DNA fragmentation analysis. The ﬁgure is
representative of four independent experiments.
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assays conﬁrmed the early induction of apoptosis in insect cells
by the expression of rM and rMH.3.4. Absence of apoptosis in mammalian cells expressing rM and
rMH
To examine whether rM and rMH also induced apoptosis in
mammalian cells, we constructed vBacMam-EYFP, vBac-
Mam-M and vBacMam-MH for the expression of EYFP, rM
and rMH in mammalian cells. These viruses were used to trans-
duce mammalian cells of diﬀerent origins, including A549, Vero
E6, HeLa, BEAS-2B, 293, HuH-7 and RD cells, and the expres-
sion was conﬁrmed by Western blot (data not shown). As a
control, the cells were also mock-transduced. The transduced
and mock-transduced cells were analyzed for the percentages
of sub-G1 phase cells. As shown in Fig. 5, the transduction
by vBacMam-M and vBacMam-MH resulted in sub-G1 per-
centages below 10% in all cell types tested, which were statically
similar to the percentages in the mock-transduced or vBac-
Mam-EYFP-transduced cells (P > 0.05) and indicated the
absence of apoptosis induced by rM and rMH.4. Discussion
The importance of M protein in the life cycle of coronavi-
ruses and elicitation of immunity makes it an attractive target
for anti-SARS drug research, vaccine development and the
establishment of a serological detection assay. To obtain large
quantities of recombinant SARS-CoV M protein, the recombi-
nant baculovirus vBacMH expressing rMH protein was con-
structed for expression in insect cells and subsequent
puriﬁcation. In contrast to the soluble rNH, rMH protein
was strongly associated with membranes and formed protein
aggregates if proteins were boiled at 95 C prior to electropho-
resis. Only treatment of samples under non-denaturing condi-
tions at 37 C could partially alleviate the aggregation
problem. Such thermal aggregation was also observed for
SARS-CoV M protein expressed in Vero E6 cells and the re-
gion (a.a. 51–170) responsible for the thermal aggregation
was identiﬁed [18]. The molecular mass of rMH (29 kDa)
was consistent with that of the glycosylated M protein. These
attributes suggested the similarity between recombinant M
protein expressed in insect and mammalian cells.
One unusual ﬁnding, however, was that expression of rMH
in Sf-9 cells resulted in accelerated cell death (Fig. 3A) and
high cytotoxicity (Fig. 3B). These phenomena were concomi-
tant with the early emergence of the hallmarks of apoptosis
such as cell shrinkage, nuclear condensation (Fig. 4A) and
DNA fragmentation (Fig. 4B and C) at 2 dpi, thus conﬁrming
the accelerated induction of apoptosis in insect cells by the
expression of rMH. The apoptosis was also triggered early
by the expression of rM, thus excluding the possibility that
the additional His6 tag solely accounted for the accelerated
induction. Normally, insect cells infected by wt or recombinant
baculoviruses (e.g. vBacNH, Fig. 3A) do not exhibit obvious
CPE until 3 dpi [19] because the baculovirus-encoded p35 pro-
tein blocks baculovirus-induced apoptosis in insect cells during
the early stage of virus infection [20], which is an important
strategy to prolong virus replication. The early induction of
apoptosis, therefore, interfered with viral gene expression
and virus replication and at least partly contributed to the
exceedingly low expression level (Fig. 2). Intriguingly, when
Sf-9 cells were co-infected with three recombinant baculovi-
ruses individually expressing E, M and S proteins or singly
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SARS-CoV proteins simultaneously, SARS-CoV VLPs
(virus-like particles) comprising all three proteins were ob-
tained [21,22], but no apoptosis was noted. The M protein of
other coronaviruses (e.g. MHV) accumulates in the Golgi com-
plex as homomultimeric complexes when expressed alone [23].
However, in combination with the E protein, M protein is re-
tained in the budding compartment and interacts with E pro-
tein to assemble into VLPs which are exported from the cell
[24]. Similarly, SARS-CoV M protein is a triple-spanning
membrane protein and predominantly localizes in the Golgi
[25]; it is thus reasonable to hypothesize that when expressed
alone, M protein accumulated in the Golgi and jammed the
sorting of other cellular proteins, thereby triggering the apop-
tosis. But when co-expressed with E and S proteins, M protein
interacted with other proteins to assemble into VLPs that were
released all over in the cytoplasm [22] or bud out of the cells
[21], thus no apoptosis was observed.
It has been shown that in mammalian cells apoptosis can be
induced by SARS-CoV 3a [26] and 7a [27] proteins, and even
N protein under restricted conditions [28], yet M protein has
never been implicated in apoptosis. Our data again conﬁrmed
that M protein, with or without His6 tag, did not induce appre-
ciable apoptosis in the mammalian cells (Fig. 5). However, we
found, for the ﬁrst time, that the expression SARS-CoV M
protein triggered early induction of apoptosis in insect cells
and led to low expression levels. The discrepancy was probably
due to the diﬀerences in cell type. Furthermore, the baculovi-
rus-expressed rM and rMH proteins were highly insoluble, dif-
ﬁcult to extract from cell lysates and prone to thermal
aggregation. These attributes created extra diﬃculties in the
production of full-length M protein using the baculovirus/in-
sect cell expression system. One possible solution to this hurdle
is the fusion of a signal peptide and removal of the transmem-
brane domain (a.a. 21–99) [29] while leaving the immunodom-
inant epitopes [11] intact. This concept has been demonstrated
feasible as high level expression of SARS-CoV M protein lack-
ing the transmembrane domain in Pichia pastoris was achieved
and no apoptosis was reported [30]. However, the glycosyla-
tion pattern, a property critical to the M protein activity,
necessitates further investigation. Alternatively, SARS-CoVM protein may be co-expressed with E protein and co-puriﬁed
in the form of VLP.Acknowledgements: We thank Dr. Pei-Jer Chen for providing vectors
harboring the N andM genes. We are also grateful to the ﬁnancial sup-
port from the National Science Council (NSC 92-2751-B-007-001-Y)
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